{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:40:46Z","timestamp":1782931246023,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ES101074"],"award-info":[{"award-number":["ES101074"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["HHSN273201600011C"],"award-info":[{"award-number":["HHSN273201600011C"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Social & Scientific Systems, Inc"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jaut.2018.05.006","type":"journal-article","created":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T01:08:24Z","timestamp":1526605704000},"page":"93-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Prescription medication use and antinuclear antibodies in the United States, 1999\u20132004"],"prefix":"10.1016","volume":"92","author":[{"given":"Gregg E.","family":"Dinse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine G.","family":"Parks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen C.S.","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroll A.","family":"Co","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3938-9503","authenticated-orcid":false,"given":"Edward K.L.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd A.","family":"Jusko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick W.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2018.05.006_bib1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJM200108023450506","article-title":"Autoimmune Diseases","volume":"vol. 345","author":"Davidson","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2018.05.006_bib2","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.autrev.2017.07.012","volume":"16","author":"Giacomelli","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2018.05.006_bib3","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/art.34380","article-title":"Prevalence and sociodemographic correlates of antinuclear antibodies in the United States","volume":"64","author":"Satoh","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.05.006_bib4","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1158\/1055-9965.EPI-14-0429","article-title":"Reproductive and hormonal risk factors for antinuclear antibodies (ANA) in a representative sample of U.S. women","volume":"23","author":"Parks","year":"2014","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.jaut.2018.05.006_bib5","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/art.37801","article-title":"Associations of autoantibodies, autoimmune risk alleles, and clinical diagnoses from the electronic medical records in rheumatoid arthritis cases and non-rheumatoid arthritis controls","volume":"65","author":"Liao","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.05.006_bib6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0049-0172(98)80047-4","article-title":"Autoantibodies and common viral illnesses","volume":"27","author":"Hansen","year":"1998","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.05.006_bib7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ncprheum0708","article-title":"Drug insight: autoimmune effects of medications-what's new?","volume":"4","author":"Mongey","year":"2008","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"10.1016\/j.jaut.2018.05.006_bib8","doi-asserted-by":"crossref","first-page":"J266","DOI":"10.1016\/j.jaut.2009.11.012","article-title":"Drugs and autoimmunity--a contemporary review and mechanistic approach","volume":"34","author":"Chang","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.05.006_bib9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jaut.2012.05.002","article-title":"Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences expert panel workshop","volume":"39","author":"Miller","year":"2012","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.05.006_bib10","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1289\/ehp.1409345","article-title":"Associations between selected xenobiotics and antinuclear antibodies in the National Health and Nutrition Examination Survey, 1999-2004","volume":"124","author":"Dinse","year":"2016","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.jaut.2018.05.006_bib11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jaut.2012.05.001","article-title":"Criteria for environmentally associated autoimmune diseases","volume":"39","author":"Miller","year":"2012","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.05.006_bib12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.tox.2004.12.025","article-title":"Drug-induced lupus","volume":"209","author":"Rubin","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.jaut.2018.05.006_bib13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1517\/14740338.2015.995089","article-title":"Drug-induced lupus","volume":"14","author":"Rubin","year":"2015","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.jaut.2018.05.006_bib14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaut.2014.01.005","article-title":"Diagnosis and classification of drug-induced autoimmunity (DIA)","volume":"48\u201349","author":"Xiao","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.05.006_bib15","series-title":"Anthropometric Standardization Reference Manual","author":"Lohman","year":"1988"},{"key":"10.1016\/j.jaut.2018.05.006_bib16","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2147\/IJWH.S52381","article-title":"Pregnancy-associated breast cancer: optimal treatment options","volume":"6","author":"Cardonick","year":"2014","journal-title":"Int. J. Womens Health"},{"key":"10.1016\/j.jaut.2018.05.006_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/epirev\/mxt006","article-title":"Pregnancy characteristics and women's future cardiovascular health: an underused opportunity to improve women's health?","volume":"36","author":"Rich-Edwards","year":"2014","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.jaut.2018.05.006_bib18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/1529-0131(200002)43:2<243::AID-ANR2>3.0.CO;2-K","article-title":"Approaches for identifying and defining environmentally associated rheumatic disorders","volume":"43","author":"Miller","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.05.006_bib19","series-title":"Regression Modeling Strategies: with Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis","author":"Harrell","year":"2015"},{"key":"10.1016\/j.jaut.2018.05.006_bib20","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2125.2010.03733.x","article-title":"Do selected drugs increase the risk of lupus? A matched case-control study","volume":"70","author":"Schoonen","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jaut.2018.05.006_bib21","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/art.22510","article-title":"Reproductive and menopausal factors and risk of systemic lupus erythematosus in women","volume":"56","author":"Costenbader","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.05.006_bib22","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/art.24398","article-title":"Combined oral contraceptive use and the risk of systemic lupus erythematosus","volume":"61","author":"Bernier","year":"2009","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jaut.2018.05.006_bib23","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nrrheum.2014.144","article-title":"Modulation of autoimmune rheumatic diseases by oestrogen and progesterone","volume":"10","author":"Hughes","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2018.05.006_bib24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/acel.12326","article-title":"How sex and age affect immune responses, susceptibility to infections, and response to vaccination","volume":"14","author":"Giefing-Kroll","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.jaut.2018.05.006_bib25","doi-asserted-by":"crossref","first-page":"e1202","DOI":"10.1097\/MJT.0000000000000283","article-title":"Ciprofloxacin as a trigger for bullous pemphigoid: the second case in the literature","volume":"23","author":"Cozzani","year":"2016","journal-title":"Am. J. Therapeut."},{"key":"10.1016\/j.jaut.2018.05.006_bib26","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1365-2141.2011.08784.x","article-title":"Drug induced immune haemolytic anaemia in the Berlin case-control surveillance study","volume":"154","author":"Garbe","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jaut.2018.05.006_bib27","first-page":"562","article-title":"2nd. Furosemide-induced bullous pemphigoid: case report and review of literature","volume":"5","author":"Lee","year":"2006","journal-title":"J. Drugs Dermatol. JDD"},{"key":"10.1016\/j.jaut.2018.05.006_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0190-9622(99)70414-7","article-title":"Drug-induced linear IgA bullous dermatosis probably induced by furosemide","volume":"41","author":"Cerottini","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2018.05.006_bib29","first-page":"372","article-title":"Autoimmune haemolytic anaemia due to Omeprazole","volume":"100","author":"Butt","year":"2007","journal-title":"Ir. Med. J."},{"key":"10.1016\/j.jaut.2018.05.006_bib30","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00004836-199709000-00011","article-title":"Omeprazole-induced interstitial nephritis","volume":"25","author":"Yip","year":"1997","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.05.006_bib31","first-page":"411","article-title":"Epidemiological risk factors in microscopic colitis: a prospective case-control study","volume":"19","author":"Fernandez-Banares","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jaut.2018.05.006_bib32","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(94)92008-7","article-title":"Autoimmune syndrome induced by omeprazole [letter]","volume":"344","author":"Sivakumar","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2018.05.006_bib33","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00228-011-1184-3","article-title":"Drug-induced immune thrombocytopaenia: results from the Berlin case-control surveillance study","volume":"68","author":"Garbe","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jaut.2018.05.006_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.coph.2011.02.004","article-title":"5-HT and the immune system","volume":"11","author":"Ahern","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jaut.2018.05.006_bib35","doi-asserted-by":"crossref","first-page":"10466","DOI":"10.1074\/jbc.M113.482299","article-title":"Neuroendocrine signaling via the serotonin transporter regulates clearance of apoptotic cells","volume":"289","author":"Tanaka","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2018.05.006_bib36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1574-695X.2011.00816.x","article-title":"Selective serotonin reuptake inhibitors attenuate the antigen presentation from dendritic cells to effector T lymphocytes","volume":"62","author":"Branco-de-Almeida","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.jaut.2018.05.006_bib37","series-title":"Rheumatic Diseases and the Environment","first-page":"33","article-title":"Genetics of environmentally-associated rheumatic disease","author":"Miller","year":"1999"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841118301331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841118301331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:20:04Z","timestamp":1760257204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841118301331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":37,"alternative-id":["S0896841118301331"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2018.05.006","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prescription medication use and antinuclear antibodies in the United States, 1999\u20132004","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2018.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}